BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS

  March 24, 2025

   · 

  3 min read
• Press Releases

  Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk

  March 24, 2025

   · 

  8 min read
• Press Releases

  DNAnexus Announces Collaboration with AlidaBio to Enhance RNA Modification and Expression Analysis

  March 24, 2025

   · 

  4 min read
• Press Releases

  Vicero Welcomes Renowned Cancer Immunotherapy Experts to its Scientific Advisory Board

  March 24, 2025

   · 

  4 min read
• Press Releases

  Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025

  March 24, 2025

   · 

  6 min read
• 

  Weight loss

  Novo Challenges Lilly With up to $2B Bet for Triple-G Obesity Drug From Chinese Biotech

  Novo will license UTB251, a triple hormone receptor agonist that in mid-2023 achieved 24% weight reduction at 48 weeks in a mid-stage study.

  March 24, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

  March 24, 2025

   · 

  5 min read
• Press Releases

  Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose

  March 24, 2025

   · 

  12 min read
• Press Releases

  ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference

  March 24, 2025

   · 

  1 min read
• Press Releases

  Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models

  March 24, 2025

   · 

  9 min read